Researchers discover master regulator that drives majority of lymphoma
A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein. However, a research team, led by investigators at Weill Cornell ...
Cancer
May 13, 2013 |
5 / 5 (2) |
0
|
House bill shifts funds in health care law
(AP)—House Republicans are coming to the aid of high-risk patients trying to get insurance under the new health care law. But they do so by diverting money from a prevention program that is key to the law, ensuring stiff ...
Health
Apr 24, 2013 |
5 / 5 (1) |
0
New ASTRO white paper recommends peer review to increase quality assurance and safety
The American Society for Radiation Oncology (ASTRO) has issued a new white paper, "Enhancing the role of case-oriented peer review to improve quality and safety in radiation oncology: Executive Summary," that recommends increased ...
Cancer
Mar 21, 2013 |
not rated yet |
0
Platelet-rich plasma significantly improves outcomes in patients with tennis elbow
Platelet rich plasma (PRP) therapy has been used to manage pain associated with torn tendons, muscles and ligaments, mostly in athletes, at all levels. Though it has anecdotally been successful, the evidence to support its ...
Surgery
Mar 21, 2013 |
not rated yet |
0
Researchers identify a promising target for multiple sclerosis treatments
A team of basic and clinical scientists led by the University of Montreal Hospital Research Centre's (CRCHUM) Dr. Nathalie Arbour has opened the door to significantly improved treatments for the symptoms of Multiple Sclerosis ...
Immunology
Mar 19, 2013 |
5 / 5 (3) |
0
|
Black and Hispanic patients less likely to complete substance abuse treatment, study shows
Roughly half of all black and Hispanic patients who enter publicly funded alcohol treatment programs do not complete treatment, compared to 62 percent of white patients, according to a new study from a team of researchers ...
Addiction
Jan 07, 2013 |
4 / 5 (1) |
0
Researchers shed light on the workings of the body's immune response
Researchers from Queen Mary, University of London have discovered that two proteins which are believed to play a key role in controlling the body's immune response are found in lower levels in T lymphocytes from patients ...
Immunology
Dec 12, 2012 |
5 / 5 (1) |
0
|
Pre-clinical data shows Angiocidin effective against leukemia
Angiocidin, a novel tumor-inhibiting protein, has been shown to reduce acute myeloid leukemia (AML) cells in vivo by almost two-thirds in pre-clinical experiments.
Cancer
Dec 09, 2012 |
not rated yet |
0
Genotype predicts treatment related mortality (TRM) in African-American and Asian pediatric AML patients
New research suggests that the presence of a specific genetic marker, known as WT1 SNP rs16754, may be associated with reduced toxicity from chemotherapy in African-American and Asian children with acute myeloid leukemia ...
Cancer
Dec 09, 2012 |
not rated yet |
0
Rituximab shows promise for clinical problems tied to antiphospholipid antibodies
Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease ...
Arthritis & Rheumatism
Nov 20, 2012 |
not rated yet |
0
|
Vitamin D may prevent clogged arteries in diabetics
People with diabetes often develop clogged arteries that cause heart disease, and new research at Washington University School of Medicine in St. Louis suggests that low vitamin D levels are to blame.
Diabetes
Nov 13, 2012 |
5 / 5 (2) |
0
|
Black patients with kidney cancer have poorer survival than whites
Among patients with the most common form of kidney cancer, whites consistently have a survival advantage over blacks, regardless of patient and tumor characteristics or surgical treatment. That is the conclusion of a new ...
Cancer
Nov 12, 2012 |
not rated yet |
0
Routine blood test predicts prognosis in aggressive skin cancer
A routine blood test may help predict survival in patients with an aggressive form of skin cancer known as Merkel cell carcinoma, according to new findings by Fox Chase Cancer Center researchers. The results will be presented ...
Cancer
Oct 31, 2012 |
not rated yet |
0
Hunting for the last remaining tumour cell
The 7.5 millilitres of blood contained in a standard sample tube is not nearly enough to detect circulating tumour cells (CTCs) in the blood of patients with metastatic breast cancer, prostate cancer, or ...
Cancer
Oct 29, 2012 |
not rated yet |
0
Black patients received less clinical trial information than white patients
A study comparing how physicians discuss clinical trials during clinical interactions with black patients versus white patients further confirms racial disparities in the quality of communication between physicians and patients.
Cancer
Oct 29, 2012 |
not rated yet |
0
